Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 3/20 | 0.36 |
| ▸ | PTGER1 | P34995 | 1/20 | 0.36 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | PTGER2 | P43116 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8374665 | 0.67 | PTGER4 (0.44) | PTGER4PTGER1PTGER3 | |
| SCHEMBL7606458 | 0.67 | PTGER1 (0.39) | PTGER4PTGER1PTGER3 | |
| SCHEMBL8771905 | 0.66 | ALDH1A1 (0.30) | — | |
| SCHEMBL8015572 | 0.66 | PTGER1 (0.40) | PTGER4PTGER1PTGER3 | |
| SCHEMBL21846831 | 0.64 | CRBN (0.34) | — | |
| SCHEMBL5027006 | 0.63 | FFAR4 (0.50) | CA2 | |
| Methylhydrazine SCHEMBL10992520 | 0.62 | HSP90AA1 (0.40) | — | |
| SCHEMBL8061413 | 0.62 | PTGER1 (0.37) | PTGER4PTGER1PTGER3 | |
| SCHEMBL21911678 | 0.61 | ALDH1A1 (0.39) | — | |
| SCHEMBL28063205 | 0.61 | FFAR4 (0.52) | CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5670507-A | Method for reversing multiple drug resistant phenotype | CELL THERAPEUTICS, INC. (US) | 1997-09-23 | — | — | US | disclosed |